Monday, September 26, 2016
 
 
Video: Page (1) of 1 - 02/24/11 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Dynavax Technology Up 2.03% as DSMB Approves Heplisav Studie

By DMO Affiliate
Shares of Dynavax Technologies (DVAX) are up 2.03% after the company announced today that the Data Safety Monitoring Board, established for the company's two ongoing Phase 3 trials for HEPLISAV, has completed its planned safety assessments and determined
Dynavax Technology Up 2.03% as DSMB Approves Heplisav Studie




Page: 1


null
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines